Xponance Inc. reduced its position in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 21.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 58,526 shares of the company’s stock after selling 16,433 shares during the period. Xponance Inc.’s holdings in Kimberly-Clark were worth $8,088,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its position in shares of Kimberly-Clark by 19.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock valued at $762,279,000 after acquiring an additional 944,920 shares during the period. Capital World Investors boosted its holdings in shares of Kimberly-Clark by 17.8% in the 1st quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock worth $293,559,000 after acquiring an additional 342,790 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Kimberly-Clark by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock worth $267,383,000 after acquiring an additional 354,501 shares during the last quarter. Nordea Investment Management AB increased its holdings in Kimberly-Clark by 2.9% during the 1st quarter. Nordea Investment Management AB now owns 1,720,051 shares of the company’s stock valued at $222,093,000 after purchasing an additional 48,103 shares in the last quarter. Finally, ProShare Advisors LLC raised its position in Kimberly-Clark by 9.8% in the 1st quarter. ProShare Advisors LLC now owns 1,487,835 shares of the company’s stock valued at $192,451,000 after purchasing an additional 132,576 shares during the last quarter. 76.29% of the stock is owned by hedge funds and other institutional investors.
Kimberly-Clark Stock Up 0.3 %
Shares of NYSE:KMB opened at $141.21 on Tuesday. The company has a debt-to-equity ratio of 5.59, a current ratio of 0.85 and a quick ratio of 0.58. The business’s 50-day moving average is $142.30 and its 200-day moving average is $136.29. The company has a market capitalization of $47.55 billion, a price-to-earnings ratio of 25.96, a P/E/G ratio of 3.04 and a beta of 0.39. Kimberly-Clark Co. has a 1 year low of $116.32 and a 1 year high of $149.30.
Kimberly-Clark Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 2nd. Stockholders of record on Friday, September 6th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Friday, September 6th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.46%. Kimberly-Clark’s dividend payout ratio is currently 89.71%.
Insider Buying and Selling at Kimberly-Clark
In other Kimberly-Clark news, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $140.84, for a total transaction of $250,695.20. Following the completion of the transaction, the insider now owns 7,377 shares of the company’s stock, valued at $1,038,976.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Jeffrey P. Melucci sold 37,699 shares of Kimberly-Clark stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the transaction, the insider now owns 19,935 shares in the company, valued at approximately $2,819,207.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Gonzalo Uribe sold 1,780 shares of the company’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total transaction of $250,695.20. Following the sale, the insider now owns 7,377 shares in the company, valued at $1,038,976.68. The disclosure for this sale can be found here. Insiders own 0.62% of the company’s stock.
Wall Street Analyst Weigh In
KMB has been the subject of a number of research reports. Argus upgraded Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. BNP Paribas began coverage on Kimberly-Clark in a report on Monday, June 24th. They issued a “neutral” rating and a $146.00 price target for the company. StockNews.com cut Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 30th. Deutsche Bank Aktiengesellschaft raised their price objective on Kimberly-Clark from $139.00 to $142.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Finally, JPMorgan Chase & Co. raised their price objective on Kimberly-Clark from $123.00 to $135.00 and gave the stock an “underweight” rating in a research note on Monday, July 22nd. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $145.67.
Get Our Latest Research Report on KMB
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More
- Five stocks we like better than Kimberly-Clark
- High Dividend REITs: Are They an Ideal Way to Diversify?
- The Average 401k Balance by Age Explained
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How Investors Can Find the Best Cheap Dividend Stocks
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.